Prognostic models for acute liver failure

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 2, 2010, Pages 122-128

  Du, Wei Bo ^a   Pan, Xiao Ping ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute liver failure; Liver transplantation; Model for end stage liver disease score; Prognosis; The King's College Hospital criteria

Indexed keywords

ALPHA FETOPROTEIN; AMMONIA; LACTIC ACID; PHOSPHATE; VITAMIN D BINDING PROTEIN;

AMMONIA BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; LIVER FAILURE; PHOSPHATE BLOOD LEVEL; PROGNOSIS; REVIEW; SCORING SYSTEM; SURVIVAL;

ALPHA-FETOPROTEINS; AMMONIA; HUMANS; LACTIC ACID; LIVER FAILURE, ACUTE; MODELS, BIOLOGICAL; PHOSPHATES; PROGNOSIS; VITAMIN D-BINDING PROTEIN;

EID: 77951796813     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005;11:594-605. (Pubitemid 40872895)
2. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.
3. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996;16:415-425. (Pubitemid 27074783)
4. Detry O, Arkadopoulos N, Ting P, Kahaku E, Watanabe FD, Rozga J, et al. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999;65:934-938. (Pubitemid 29471317)
5. Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, Yang Q, et al. Artificial liver support system in China: a review over the last 30 years. Ther Apher Dial 2006;10:160-167.
6. Cholongitas EB, Betrossian A, Leandro G, Shaw S, Patch D, Burroughs AK. King's criteria, APACHE II, and SOFA scores in acute liver failure. Hepatology 2006;43:882.
7. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445. (Pubitemid 19192181)
8. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl 2007;13:814-821.
9. Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 2009;15:600-609.
10. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6: 163-169. (Pubitemid 30173994)
11. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997;26:62-68. (Pubitemid 27072605)
12. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871. (Pubitemid 30169932)
13. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005;37:4359-4364. (Pubitemid 43016031)
14. Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 2006;21:1519-1524.
15. Zaman MB, Hoti E, Qasim A, Maguire D, McCormick PA, Hegarty JE, et al. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc 2006;38:2097-2098. (Pubitemid 46068453)
16. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 2007;27:329-334. (Pubitemid 46416622)
17. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007;45:789-796. (Pubitemid 46450630)
18. Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393-401.
19. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-828.
20. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:16521660. (Pubitemid 43668830)
21. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002;359:558-563. (Pubitemid 34178437)
22. Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006;34:337-343.
23. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003;9:248-253.
24. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41:32-39. (Pubitemid 40066380)
25. Schiodt FV, Bondesen S, Petersen I, Dalhoff K, Ott P, Tygstrup N. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure. Hepatology 1996;23:713-718. (Pubitemid 126664270)
26. Schiodt FV, Bangert K, Shakil AO, McCashland T, Murray N, Hay JE, et al. Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl 2007;13:1324-1329. (Pubitemid 47457062)
27. Antoniades CG, Berry PA, Bruce M, Cross TJ, Portal AJ, Hussain MJ, et al. Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl 2007;13:1254-1261. (Pubitemid 47457052)
28. Baquerizo A, Anselmo D, Shackleton C, Chen TW, Cao C, Weaver M, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation 2003;75: 2007-2014. (Pubitemid 36793283)
29. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002;36:659-665. (Pubitemid 34977176)
30. Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 2006;55:98-104. (Pubitemid 41820642)
31. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007;46:1844-1852.
32. Davern TJ. Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema. Hepatology 2007; 46:1679-1681.
33. Murray-Lyon IM, Orr AH, Gazzard B, Kohn J, Williams R. Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut 1976;17:576-580.
34. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005;41:26-31. (Pubitemid 40066379)
35. Schiodt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006;12:1776-1781. (Pubitemid 44911803)
36. Yang SS, Cheng KS, Lai YC, Wu CH, Chen TK, Lee CL, et al. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. J Gastroenterol 2002;37:626-632.
37. Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990; 301:964-966. (Pubitemid 20362194)
38. Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993;18:1370-1376. (Pubitemid 23348424)
39. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470. (Pubitemid 32119037)
40. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903. (Pubitemid 38670122)
41. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96. (Pubitemid 36055342)
42. Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007;7:1624-1628. (Pubitemid 46776260)
43. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13: 523-529. (Pubitemid 46605854)
44. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004;10:995-1000. (Pubitemid 39232753)
45. Xiol X, Gines P, Castells L, Twose J, Ribalta A, FuentesArderiu X, et al. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl 2009;15:300-305.
46. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Re-weighting the model for end-stage liver disease score components. Gastroenterology 2008;135:1575-1581.
47. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-1061. (Pubitemid 44063778)
48. Schiodt FV. Gc-globulin in liver disease. Dan Med Bull 2008; 55:131-146.
49. Gressner OA, Lahme B, Gressner AM. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca(2+)dependent interaction with the megalin/gp330 receptor. Clin Chim Acta 2008;390:28-37.
50. Meier U, Gressner O, Lammert F, Gressner AM. Gc-globulin: roles in response to injury. Clin Chem 2006;52:1247-1253. (Pubitemid 43956013)
51. Schiodt FV, Bondesen S, Tygstrup N. Serial measurements of serum Gc-globulin in acetaminophen intoxication. Eur J Gastroenterol Hepatol 1995;7:635-640.
52. Schiodt FV, Ott P, Bondesen S, Tygstrup N. Reduced serum Gc-globulin concentrations in patients with fulminant hepatic failure: association with multiple organ failure. Crit Care Med 1997;25:1366-1370. (Pubitemid 27347302)
53. Riordan SM, Williams R. Blood lactate and outcome of paracetamol-induced acute liver failure. Lancet 2002;360: 573-574.
54. Murphy ND, Kodakat SK, Wendon JA, Jooste CA, Muiesan P, Rela M, et al. Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med 2001;29:2111-2118. (Pubitemid 33063538)
55. Cholongitas E, O'Beirne J, Betrossian A, Senzolo M, Shaw S, Patch D, et al. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14:121-123. (Pubitemid 351168003)
56. Schmidt LE, Larsen FS. Blood lactate as a prognostic marker in acetaminophen-induced acute liver failure. Hepatology 2003;37:1199-1201. (Pubitemid 36538698)
57. Bernardi M, Tacconi C, Somaroli M, Gasbarrini G, Mazziotti A. Hyperammonemic, ammonia-independent coma in experimental acute liver failure induced in the pig. Gastroenterology 1981;81:191-192.
58. Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992;15:449-453.
59. Quiró-Tejeira RE, Molina RA, Katzir L, Lie A, Vargas JH, Ament ME, et al. Resolution of hypophosphatemia is associated with recovery of hepatic function in children with fulminant hepatic failure. Transpl Int 2005;18:1061-1066. (Pubitemid 41726775)
60. Scotto J, Opolon P, Etévé J, Vergoz D, Thomas M, Caroli J. Liver biopsy and prognosis in acute liver failure. Gut 1973;14:927-933.
61. Yamagishi Y, Saito H, Ebinuma H, Kikuchi M, Ojiro K, Kanamori H, et al. A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol 2009;44:615-623.
62. Perkins JD. Another formula to determine the prognosis of patients with acute liver failure. Liver Transpl 2009;15:986991.
63. Shakil AO, Jones BC, Lee RG, Federle MP, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000;45:334-339. (Pubitemid 30133895)
64. Sato Y, Watanabe H, Kameyama H, Kobayashi T, Yamamoto S, Takeishi T, et al. Serum LECT2 level as a prognostic indicator in acute liver failure. Transplant Proc 2004;36:2359-2361. (Pubitemid 39550844)
65. Shneider BL, Rinaldo P, Emre S, Bucuvalas J, Squires R, Narkewicz M, et al. Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology 2005;41:717-721. (Pubitemid 40462932)